Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 655 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.15mg KPG-818 dose | - | - | - | - | [1] 49 49 💬1. 0.15mg KPG-818 dose
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | 0.6mg KPG-818 dose | - | - | - | - | [1] 49 49 💬2. 0.6mg KPG-818 dose
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | 1 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬3. 1 mg/kg CNTO 136
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | 10 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬4. 10 mg/kg CNTO 136
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | 2-deoxy-2 [F-18] fluoro-2-d-glucose | [2] D-glucose D-glucose,Dextrose, unspecified form | [1] Glucose
Glucose
💬5. 2-deoxy-2 [F-18] fluoro-2-d-glucose
| - | - | [1] 49 49 💬5. 2-deoxy-2 [F-18] fluoro-2-d-glucose
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | 2mg KPG-818 dose | - | - | - | - | [1] 49 49 💬6. 2mg KPG-818 dose
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | 4 mg/kg CNTO 136 | - | - | - | - | [1] 49 49 💬7. 4 mg/kg CNTO 136
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | 81mg aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬8. 81mg aspirin
| [2] PTGS1 PTGS1,PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemi ... | [1] 49 49 💬8. 81mg aspirin
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | A-623 | - | - | - | - | [1] 49 49 💬9. A-623
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬10. Abatacept
| [2] CD80 CD80,CD86 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 [13] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host dis ... | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271 ... 10. Abatacept
|